Sven A. Danner

7.3k total citations · 2 hit papers
78 papers, 5.9k citations indexed

About

Sven A. Danner is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sven A. Danner has authored 78 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Virology, 45 papers in Infectious Diseases and 20 papers in Epidemiology. Recurrent topics in Sven A. Danner's work include HIV Research and Treatment (48 papers), HIV/AIDS drug development and treatment (38 papers) and HIV/AIDS Research and Interventions (29 papers). Sven A. Danner is often cited by papers focused on HIV Research and Treatment (48 papers), HIV/AIDS drug development and treatment (38 papers) and HIV/AIDS Research and Interventions (29 papers). Sven A. Danner collaborates with scholars based in Netherlands, Vietnam and United States. Sven A. Danner's co-authors include Daan W. Notermans, Michiel A. van Agtmael, Joep M. A. Lange, John M. Leonard, Jaap Goudsmit, Marijke Roos, Peter Reiss, Remco P. H. Peters, Christina M. J. E. Vandenbroucke‐Grauls and Frank Miedema and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Sven A. Danner

78 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation

1998 606 citations Daan W. Notermans, Rob J. de Boer et al. profile →
Kinetics of Response in Lymphoid Tissues to Antiretroviral Therapy of HIV-1 Infection

1997 522 citations Daan W. Notermans, Jaap Goudsmit et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven A. Danner Netherlands	40	3.7k	3.6k	1.4k	1.2k	953	78	5.9k
Patrice Massip France	40	2.3k 0.6×	2.5k 0.7×	1.0k 0.7×	695 0.6×	492 0.5×	127	4.0k
Jacques Reynes France	44	3.9k 1.1×	5.0k 1.4×	2.3k 1.6×	1.3k 1.1×	1.0k 1.1×	207	8.1k
Cécile Tremblay Canada	39	3.2k 0.9×	2.7k 0.8×	1.7k 1.2×	723 0.6×	1.9k 2.0×	240	6.1k
Jack Fuhrer United States	19	4.2k 1.2×	6.2k 1.7×	3.4k 2.4×	2.5k 2.1×	369 0.4×	33	9.3k
Harry Lampiris United States	18	2.1k 0.6×	2.1k 0.6×	760 0.5×	944 0.8×	688 0.7×	29	3.3k
Jennifer Hoy Australia	47	3.2k 0.9×	5.3k 1.5×	2.9k 2.0×	2.8k 2.4×	483 0.5×	242	8.3k
Marshall J. Glesby United States	45	1.6k 0.4×	2.6k 0.7×	1.9k 1.3×	2.3k 2.0×	637 0.7×	179	6.3k
Félix Gutiérrez Spain	42	2.2k 0.6×	3.7k 1.0×	2.2k 1.5×	1.7k 1.4×	349 0.4×	281	6.5k
Gitte Kronborg Denmark	42	1.7k 0.5×	2.6k 0.7×	2.2k 1.6×	2.2k 1.9×	1.1k 1.1×	168	6.5k
Peré Domingo Spain	51	3.8k 1.0×	5.2k 1.4×	2.3k 1.7×	3.1k 2.6×	479 0.5×	392	9.5k

Countries citing papers authored by Sven A. Danner

Since Specialization

Citations

This map shows the geographic impact of Sven A. Danner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven A. Danner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven A. Danner more than expected).

Fields of papers citing papers by Sven A. Danner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven A. Danner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven A. Danner. The network helps show where Sven A. Danner may publish in the future.

Co-authorship network of co-authors of Sven A. Danner

This figure shows the co-authorship network connecting the top 25 collaborators of Sven A. Danner. A scholar is included among the top collaborators of Sven A. Danner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven A. Danner. Sven A. Danner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schueren, M.A.E. de van der, et al.. (2013). Prevalence and determinants for malnutrition in geriatric outpatients. Clinical Nutrition. 32(6). 1007–1011. 144 indexed citations

Vonderen, Marit G. A. van, Yvo M. Smulders, Coen D.A. Stehouwer, et al.. (2009). Carotid Intima-Media Thickness and Arterial Stiffness in HIV-Infected Patients: The Role of HIV, Antiretroviral Therapy, and Lipodystrophy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(2). 153–161. 78 indexed citations

Lips, Paul, Michiel A. van Agtmael, Elly A. Hassink, et al.. (2009). First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. AIDS. 23(11). 1367–1376. 83 indexed citations

Vliet, Hans van, Marit G. A. van Vonderen, Johan W. Molling, et al.. (2006). Cutting Edge: Rapid Recovery of NKT Cells upon Institution of Highly Active Antiretroviral Therapy for HIV-1 Infection. The Journal of Immunology. 177(9). 5775–5778. 45 indexed citations

Peters, Remco P. H., Michiel A. van Agtmael, Sven A. Danner, Paul H. M. Savelkoul, & Christina M. J. E. Vandenbroucke‐Grauls. (2004). New developments in the diagnosis of bloodstream infections. The Lancet Infectious Diseases. 4(12). 751–760. 325 indexed citations

Weverling, Gerrit Jan, Monika Peeters, Aza Rakhmanova, et al.. (2003). TMC125 exerts similar initial antiviral potency as a five-drug, triple class antiretroviral regimen. AIDS. 17(18). 2623–2627. 33 indexed citations

Lukashov, Vladimir V., et al.. (2001). Selection by AZT and Rapid Replacement in the Absence of Drugs of HIV Type 1 Resistant to Multiple Nucleoside Analogs. AIDS Research and Human Retroviruses. 17(9). 807–818. 16 indexed citations

Notermans, Daan W., J J de Jong, Jaap Goudsmit, et al.. (2001). Potent Antiretroviral Therapy Initiates Normalization of Hypergammaglobulinemia and a Decline in HIV Type 1-Specific Antibody Responses. AIDS Research and Human Retroviruses. 17(11). 1003–1008. 67 indexed citations

Nieuwkerk, Pythia T., Elisabeth H. Gisolf, Monique H. Reijers, Joep M. A. Lange, & Sven A. Danner. (2001). Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS. 15(15). 1985–1991. 62 indexed citations

10.

Notermans, Daan W., Frank de Wolf, Peter Oudshoorn, et al.. (2000). Evaluation of a Second-Generation Nucleic Acid Sequence-Based Amplification Assay for Quantification of HIV Type 1 RNA and the Use of Ultrasensitive Protocol Adaptations. AIDS Research and Human Retroviruses. 16(15). 1507–1517. 15 indexed citations

11.

Heeswijk, Rolf P. G. van, Agnes I. Veldkamp, Jan W. Mulder, et al.. (2000). The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals. AIDS. 14(8). F77–F82. 113 indexed citations

12.

Pontesilli, Oscar, Daan W. Notermans, Norbert A. Foudraine, et al.. (1999). Functional T Cell Reconstitution and Human Immunodeficiency Virus–1–Specific Cell‐Mediated Immunity during Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 180(1). 76–86. 103 indexed citations

13.

Cameron, D. William, Margo Heath‐Chiozzi, Sven A. Danner, et al.. (1998). Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Lancet. 351(9102). 543–549. 427 indexed citations

14.

Nijhuis, Monique, Rob Schuurman, Dorien de Jong, et al.. (1997). Lamivudine‐Resistant Human Immunodeficiency Virus Type 1 Variants (184V) Require Multiple Amino Acid Changes to Become Co‐Resistant to Zidovudine In Vivo. The Journal of Infectious Diseases. 176(2). 398–405. 90 indexed citations

15.

Leeuwen, Remko van, et al.. (1992). The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection. AIDS. 6(12). 1471–1476. 99 indexed citations

16.

Wouw, Poll A. van der, Remko van Leeuwen, Rien H. J. Van Oers, Joep M. A. Lange, & Sven A. Danner. (1991). Effects of recombinant human granulocyte colony‐stimulating factor on leucopenia in zidovudine‐treated patients with AIDS and AIDS related complex, a phase I/II study. British Journal of Haematology. 78(3). 319–324. 33 indexed citations

17.

Storosum, Jitschak G., et al.. (1991). Attitudes of health-care workers towards AIDS at three Dutch hospitals. AIDS. 5(1). 55–60. 21 indexed citations

18.

Reiss, Peter, Joep M. A. Lange, Anthony de Ronde, et al.. (1990). Antibody response to viral proteins U (vpu) and R (vpr) in HIV-1-infected individuals.. PubMed. 3(2). 115–22. 20 indexed citations

19.

Wit, Ronald de, et al.. (1989). Lack of activity of zidovudine in AIDS-associated Kaposiʼs sarcoma. AIDS. 3(12). 847–850. 16 indexed citations

20.

Bakker, Piet, et al.. (1988). Etoposide for epidemic Kaposi's sarcoma: A phase II study. European Journal of Cancer and Clinical Oncology. 24(6). 1047–1048. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact